J.L. Bainbridge & Co’s CVS Health CVS Stock Holding History

J.L. Bainbridge & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,000	Closed	-$4.05M	–	80
2022 Q1	$4.05M	Hold	40,000	–	–	0.46%	23
2021 Q4	$4.13M	Sell	40,000 -20,000	-33%	-$1.85M	0.46%	25
2021 Q3	$5.09M	Hold	60,000	–	–	0.61%	24
2021 Q2	$5M	Hold	60,000	–	–	0.6%	24
2021 Q1	$4.51M	Hold	60,000	–	–	0.6%	22
2020 Q4	$4.1M	Buy	60,000 +10,000	+20%	+$650K	0.58%	23
2020 Q3	$2.92M	Buy	50,000 +30,000	+150%	+$1.87M	0.46%	21
2020 Q2	$1.3M	Hold	20,000	–	–	0.24%	24
2020 Q1	$1.19M	Buy	20,000 +10,000	+100%	+$668K	0.23%	25
2019 Q4	$743K	Buy	+10,000	New	+$702K	0.1%	34

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

J.L. Bainbridge & Co's CVS Position: Q3 2022 in Review

J.L. Bainbridge & Co sold out of CVS Health (CVS) in Q3 2022, closing a stake of 2,891 shares — an estimated $268K sold.

J.L. Bainbridge & Co first reported a position in CVS in Q4 2019 and held it in 11 quarters. The position peaked at $49.1M in Q4 2021. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

J.L. Bainbridge & Co reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
J.L. Bainbridge & Co sold 2,891 CVS Health shares in Q3 2022, an estimated $268K.
J.L. Bainbridge & Co first reported a position in CVS Health in Q4 2019 and held it in 11 quarters.
J.L. Bainbridge & Co's CVS Health position peaked at $49.1M in Q4 2021.
2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on J.L. Bainbridge & Co's 13F filing for Q3 2022, filed 2 Nov 2022.